(Answered) : ICA: Marketing Ethics: India’s Bitter Pill India’s Supreme Court delivered what might be the final nail in the coffin of

ICA: Marketing Ethics: India’s Bitter Pill

India’s Supreme Court delivered what might be the final nail in the coffin of pharmaceutical innovation in India by rejecting Novaritis’ attempt to win patent protection for a potentially life-saving drug. The ruling comes after more than six years of legal battles. Other multinational pharmaceutical companies have suffered setbacks related to patents as well. Bayer’s patent for its expensive cancer drug was revoked after being challenged by an Indian generic drug manufacturer, and Bayer was even ordered to issue a license to the Indian company so it could copy Bayer’s drug and sell it for